Effects of EGIS-7625, a selective and competitive 5-HT2B receptor antagonist.
Kovács A, Gacsályi I, Wellmann J, Schmidt E, Szücs Z, Dubreuil V, Nicolas JP, Boutin J, Bózsing D, Egyed A, Tihanyi K, Spedding M, Szénási G.
Kovács A, et al.
Cardiovasc Drugs Ther. 2003 Sep-Nov;17(5-6):427-34. doi: 10.1023/b:card.0000015857.96371.43.
Cardiovasc Drugs Ther. 2003.
PMID: 15107597